| LINE ITEM (USD / %) | FY 2025
FILED 2026-05-31 | FY 2024
FILED 2025-05-31 | FY 2023
FILED 2024-05-31 |
|---|---|---|---|
| Revenue (Total Sales) | $8.79B | $8.89B | $9.42B |
| YoY Revenue Growth % | -1.1% | -5.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $540.0M | $1.40B | $1.75B |
| Operating Margin % | 6.1% | 15.8% | 18.6% |
| Net Income (GAAP) | $655.0M | $1.35B | $1.57B |
| EBITDA (Normalized) | $856.6M | $1.72B | $2.09B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $167.0M | $1.53B | $1.54B |
| Capital Expenditures (CapEx) | $395.8M | $400.1M | $424.1M |
| Free Cash Flow (FCF) | -$228.8M | $1.13B | $1.12B |
| FCF Margin % | -2.6% | 12.7% | 11.9% |
| Return on Invested Capital (ROIC %) | 6.7% | 17.2% | 20.3% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $2.47B | $2.50B | $2.65B |
| Total Stockholders' Equity | $5.07B | $5.12B | $5.43B |